These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37855309)

  • 1. The Golgi complex of dopaminergic enteric neurons is fragmented in a hemiparkinsonian rat model.
    Cara-Esteban M; Marín MP; Martínez-Alonso E; Martínez-Bellver S; Teruel-Martí V; Martínez-Menárguez JA; Tomás M
    Microsc Res Tech; 2024 Feb; 87(2):373-386. PubMed ID: 37855309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragmentation of the Golgi complex of dopaminergic neurons in human substantia nigra: New cytopathological findings in Parkinson's disease.
    Tomás M; Martínez-Alonso E; Martínez-Martínez N; Cara-Esteban M; Martínez-Menárguez JA
    Histol Histopathol; 2021 Jan; 36(1):47-60. PubMed ID: 33078843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rab1A over-expression prevents Golgi apparatus fragmentation and partially corrects motor deficits in an alpha-synuclein based rat model of Parkinson's disease.
    Coune PG; Bensadoun JC; Aebischer P; Schneider BL
    J Parkinsons Dis; 2011; 1(4):373-87. PubMed ID: 23939344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease.
    Barrenschee M; Zorenkov D; Böttner M; Lange C; Cossais F; Scharf AB; Deuschl G; Schneider SA; Ellrichmann M; Fritscher-Ravens A; Wedel T
    Acta Neuropathol Commun; 2017 Jan; 5(1):1. PubMed ID: 28057070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragmentation of Golgi apparatus of nigral neurons with alpha-synuclein-positive inclusions in patients with Parkinson's disease.
    Fujita Y; Ohama E; Takatama M; Al-Sarraj S; Okamoto K
    Acta Neuropathol; 2006 Sep; 112(3):261-5. PubMed ID: 16855830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology.
    Manfredsson FP; Luk KC; Benskey MJ; Gezer A; Garcia J; Kuhn NC; Sandoval IM; Patterson JR; O'Mara A; Yonkers R; Kordower JH
    Neurobiol Dis; 2018 Apr; 112():106-118. PubMed ID: 29341898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Synuclein Propagation Mouse Models of Parkinson's Disease.
    Uemura N; Ueda J; Okuda S; Sawamura M; Takahashi R
    Methods Mol Biol; 2021; 2322():119-130. PubMed ID: 34043198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nigral overexpression of α-synuclein in a rat Parkinson's disease model indicates alterations in the enteric nervous system and the gut microbiome.
    O'Donovan SM; Crowley EK; Brown JR; O'Sullivan O; O'Leary OF; Timmons S; Nolan YM; Clarke DJ; Hyland NP; Joyce SA; Sullivan AM; O'Neill C
    Neurogastroenterol Motil; 2020 Jan; 32(1):e13726. PubMed ID: 31576631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nature of catecholamine-containing neurons in the enteric nervous system in relationship with organogenesis, normal human anatomy and neurodegeneration.
    Natale G; Ryskalin L; Busceti CL; Biagioni F; Fornai F
    Arch Ital Biol; 2017 Sep; 155(3):118-130. PubMed ID: 29220864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-Dependent Alpha-Synuclein Accumulation and Phosphorylation in the Enteric Nervous System in a Transgenic Mouse Model of Parkinson's Disease.
    Zhong CB; Chen QQ; Haikal C; Li W; Svanbergsson A; Diepenbroek M; Li JY
    Neurosci Bull; 2017 Oct; 33(5):483-492. PubMed ID: 28924920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity-dependent secretion of alpha-synuclein by enteric neurons.
    Paillusson S; Clairembault T; Biraud M; Neunlist M; Derkinderen P
    J Neurochem; 2013 May; 125(4):512-7. PubMed ID: 23278133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut-to-Brain α-Synuclein Transmission in Parkinson's Disease: Evidence for Prion-like Mechanisms.
    Chen M; Mor DE
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Expression of Neuronal Dopaminergic Markers in a Parkinson's Disease Model in Rats Implanted with Enteric Stem Cells (ENSCs).
    Parra-Cid C; Orozco-Castillo E; García-López J; Contreras-Figueroa E; Ramos-Languren LE; Ibarra C; Carreón-Rodríguez A; Aschner M; Königsberg M; Santamaría A
    CNS Neurol Disord Drug Targets; 2020; 19(2):148-162. PubMed ID: 32303175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microenvironmental changes as a potential trigger in Parkinson's disease through the gut-brain axis.
    Chen SJ; Lin CH
    J Biomed Sci; 2022 Jul; 29(1):54. PubMed ID: 35897024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of tau in the human and rodent enteric nervous system under physiological conditions and in tauopathy.
    Lionnet A; Wade MA; Corbillé AG; Prigent A; Paillusson S; Tasselli M; Gonzales J; Durieu E; Rolli-Derkinderen M; Coron E; Duchalais E; Neunlist M; Perkinton MS; Hanger DP; Noble W; Derkinderen P
    Acta Neuropathol Commun; 2018 Jul; 6(1):65. PubMed ID: 30037345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focus on the Small GTPase Rab1: A Key Player in the Pathogenesis of Parkinson's Disease.
    Martínez-Menárguez JÁ; Martínez-Alonso E; Cara-Esteban M; Tomás M
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease.
    Shannon KM; Keshavarzian A; Mutlu E; Dodiya HB; Daian D; Jaglin JA; Kordower JH
    Mov Disord; 2012 May; 27(6):709-15. PubMed ID: 21766334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease.
    Anderson G; Noorian AR; Taylor G; Anitha M; Bernhard D; Srinivasan S; Greene JG
    Exp Neurol; 2007 Sep; 207(1):4-12. PubMed ID: 17586496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The second brain and Parkinson's disease.
    Lebouvier T; Chaumette T; Paillusson S; Duyckaerts C; Bruley des Varannes S; Neunlist M; Derkinderen P
    Eur J Neurosci; 2009 Sep; 30(5):735-41. PubMed ID: 19712093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appraisal of the dopaminergic and noradrenergic innervation of the submucosal plexus in PD.
    Corbillé AG; Coron E; Neunlist M; Derkinderen P; Lebouvier T
    J Parkinsons Dis; 2014; 4(4):571-6. PubMed ID: 25055959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.